Recombinant HIV envelope proteins fail to engage germline versions of anti-CD4bs bNAbs.
Vaccine candidates for HIV-1 so far have not been able to elicit broadly neutralizing antibodies (bNAbs) although they express the epitopes recognized by bNAbs to the HIV envelope glycoprotein (Env). To understand whether and how Env immunogens interact with the predicted germline versions of known...
Main Authors: | Sam Hoot, Andrew T McGuire, Kristen W Cohen, Roland K Strong, Lars Hangartner, Florian Klein, Ron Diskin, Johannes F Scheid, D Noah Sather, Dennis R Burton, Leonidas Stamatatos |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS Pathogens |
Online Access: | http://europepmc.org/articles/PMC3536657?pdf=render |
Similar Items
-
Correction: Recombinant HIV Envelope Proteins Fail to Engage Germline Versions of Anti-CD4bs bNAbs.
by: Sam Hoot, et al.
Published: (2013-07-01) -
Poly- and autoreactivity of HIV-1 bNAbs: implications for vaccine design
by: Joel Finney, et al.
Published: (2018-07-01) -
Virus-driven Inflammation Is Associated With the Development of bNAbs in Spontaneous Controllers of HIV
by: Dugast, Anne-Sophie, et al.
Published: (2018) -
Probabilities of developing HIV-1 bNAb sequence features in uninfected and chronically infected individuals
by: Christoph Kreer, et al.
Published: (2023-11-01) -
Beyond bNAbs: Uses, Risks, and Opportunities for Therapeutic Application of Non-Neutralising Antibodies in Viral Infection
by: Mader, K, et al.
Published: (2024)